Glycemic control in people with long-standing type 2 diabetes on basal insulin therapy has been challenging due to insulin titration inertia, but many also need additional therapy, said Julio Rosenstock, MD, Clinical Professor of Medicine at Texas Southwestern Medical Center
Cleaner profile than older non-selective GHS like GHRP-6
The distinction sounds academic until you consider what it means for appetite suppression, muscle preservation, metabolic adaptation, and long-term outcomes
For those in the second month of treatment when plateaus tend to show up for the first time what to expect in month 2 on a GLP-1 gives broader context for what that phase typically looks like
But heres what caught my attention as a psychiatrist
On October 14th, 2025, the Kerry Health and Nutrition Institute (KHNI) hosted an expert scientific webinar